Abstract:R-loops (RNA–DNA hybrids with displaced single-stranded DNA) have emerged as a potent source of DNA damage and genomic instability. The termination of defective RNA polymerase II (RNAPII) is one of the major sources of R-loop formation. 5′-3′-exoribonuclease 2 (XRN2) promotes genome-wide efficient RNAPII termination, and XRN2-deficient cells exhibit increased DNA damage emanating from elevated R-loops. Recently, we showed that DNA damage instigated by XRN2 depletion in human fibroblast cells resulted in enhanced poly(ADP-ribose) polymerase 1 (PARP1) activity. Additionally, we established a synthetic lethal relationship between XRN2 and PARP1. However, the underlying cellular stress response promoting this synthetic lethality remains elusive. Here, we delineate the molecular consequences leading to the synthetic lethality of XRN2-deficient cancer cells induced by PARP inhibition. We found that XRN2-deficient lung and breast cancer cells display sensitivity to two clinically relevant PARP inhibitors, Rucaparib and Olaparib. At a mechanistic level, PARP inhibition combined with XRN2 deficiency exacerbates R-loop and DNA double-strand break formation in cancer cells. Consistent with our previous findings using several different siRNAs, we also show that XRN2 deficiency in cancer cells hyperactivates PARP1. Furthermore, we observed enhanced replication stress in XRN2-deficient cancer cells treated with PARP inhibitors. Finally, the enhanced stress response instigated by compromised PARP1 catalytic function in XRN2-deficient cells activates caspase-3 to initiate cell death. Collectively, these findings provide mechanistic insights into the sensitivity of XRN2-deficient cancer cells to PARP inhibition and strengthen the underlying translational implications for targeted therapy.

Y RNA-derived fragments in a complex with YBX1 modulate PARP1 residency at DNA double strand breaks

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

The FHA and BRCT Domains Recognize ADP-ribosylation During DNA Damage Response.

YTHDC1 cooperates with the THO complex to prevent RNA damage-induced DNA breaks

RNA-directed repair of DNA double-strand breaks.

XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites

The emerging role of RNAs in DNA damage repair

DDX18 prevents R-loop-induced DNA damage and genome instability via PARP-1

PARP1 associates with R-loops to promote their resolution and genome stability

RNA-mediated double-strand break repair by end-joining mechanisms

DNA damage-induced YTHDC1 O-GlcNAcylation promotes homologous recombination by enhancing m6A binding

Molecular Basis of XRN2-Deficient Cancer Cell Sensitivity to Poly(ADP-ribose) Polymerase Inhibition

DNA damage-induced YTHDC1 O-GlcNAcylation promotes homologous recombination by enhancing N6-methyladenosine binding

Epitranscriptome in action: RNA modifications in the DNA damage response

The dynamics and Regulation of PARP1 and PARP2 in response to DNA damage and during replication

YTHDC1 m6A-dependent and m6A-independent functions converge to preserve DNA damage response

RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response

C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption

A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites.

Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis